OR WAIT null SECS
TriRx hosts various leaders at a ribbon-cutting ceremony for their new facility.
TriRx Pharmaceutical Services hosted various state and community leaders at the ribbon-cutting ceremony celebrating the acquisition of their Shawnee, Kan. facility. In attendance were state and local government officials.
The Shawnee facility was acquired from Elanco Animal Health Incorporated on August 1, 2021. They also entered into a long-term supply agreement which will assure a reliable supply of Elanco products.
Dave Urbanek, executive vice president of manufacturing and quality for Elanco, attended the ceremony to officially grant ownership to Timothy C. Tyson, chairman and CEO of TriRx. He also thanked Elanco employees for their continuous contributions and support.
The facility, which employs approximately 300 individuals, can make parenterals, topicals, non-sterile liquids, solid oral dose, and soft chews. It features a pilot plant, quality control laboratories, veterinary technical services, and a large warehousing and distribution facility.
"We are looking forward to increasing the capabilities and efficiencies of this site’s operations,” said Tyson in a company press release. “The journey ahead will bring prosperity to TriRx, TriRx team members and stakeholders, and the broader Shawnee community. This site will represent a highly valued addition to the TriRx capabilities to continue to serve the rapidly expanding global biopharmaceutical market.”